ããã«ã¡ã¯ïŒ
ãã¬ãŒããŒè²æè¬åž«ã®äºäžè£åžã§ãã
ïœãã€ãšããäžã«âã¿ããâã£ãŠã¢ãªïŒãã·ïŒïœ
å¬ã«ãªããšèªç¶ãšé£åã«äžŠã¶ãã¿ãããããã®æè»œããšçããããã倪ãã®ã§ã¯ïŒããšæ¬é ãã人ãå€ãã®ã§ã¯ãªãã§ããããïŒ
ãããå®ã¯ãã¿ããã¯äžæã«æŽ»çšããã°ãã€ãšããã®å³æ¹ã«ãªãæç©ã§ãã
æ¬èšäºã§ã¯ãã¿ããã«å«ãŸããæ é€çŽ ããã€ãšããäžã«å¬ããåããé£ã¹æ¹ã®ã³ããªã©ãåããããã解説ããŸãã

ã¿ããã«å«ãŸããäž»ãªæ é€çŽ
ãŸãã¯ãã¿ãã1åïŒçŽ100gïŒã«å«ãŸãã代衚çãªæ é€çŽ ããã§ãã¯ããŠã¿ãŸãããã
æ é€çŽ | 嫿éïŒ100gãããïŒ | äž»ãªåã |
---|---|---|
ãšãã«ã®ãŒ | çŽ45kcal | äœã«ããªãŒ |
çæ°Žåç©ïŒç³è³ªå«ãïŒ | çŽ11g | ãšãã«ã®ãŒæºãæºè¶³æ |
é£ç©ç¹ç¶ | çŽ1.0g | è žå ç°å¢ãæŽãããæºè ¹æãå©ãã |
ãã¿ãã³C | çŽ35mg | æé žåäœçšãèãå ç«ã®ãµããŒã |
ã¯ãšã³é ž | çŽ1,000mgïŒæšå®ïŒ | ç²åŽæã®è»œæžã代è¬ãµããŒã |
β-ã¯ãªããããµã³ãã³ | 0.3ïœ0.5mg | ã«ãããã€ãã®äžçš®ãæé žåå |
ãã€ã³ãã¯ãäœã«ããªãŒã§æ é€å¯åºŠãé«ããšããããšã
ã¿ããã¯æ°Žåãå€ããèªç¶ãªçãã§æºè¶³æãåŸãããããããèå代ãããšããŠãåªç§ã§ãã
ã¿ããã®âãã€ãšããåãâãª5ã€ã®çç±
1. é£ç©ç¹ç¶ã§âç©ºè ¹æâãæãã
ã¿ããã®**èç®ïŒãããã®ãèïŒãçœãçïŒã¢ã«ããïŒ**ã«ã¯ã氎溶æ§ã»äžæº¶æ§ã®äž¡æ¹ã®é£ç©ç¹ç¶ãå«ãŸããŠããŸãã
ãããèã§æ°ŽåãåžåããŠèšãã¿ãæºè ¹æããµããŒãããŸããããã«ãè žå ã®åçèã®ãšãµã«ããªããè žå ç°å¢ã®æ¹åïŒäœå 代è¬ã®åäžã«ãè²¢ç®ããŸãã
2. ã¯ãšã³é žã§âç²ãã«ããã«ã©ãâãç¶æ
ãã€ãšããäžã¯ã©ãããŠããšãã«ã®ãŒäžè¶³ã«ãªããã¡ããããªæã«ãããããã®ãã¯ãšã³é žã§ãã
ã¯ãšã³é žã¯ãšãã«ã®ãŒä»£è¬ã«é¢ãããã¯ãšã³é žåè·¯ããæŽ»æ§åãããç²åŽæã軜æžãããšèšãããŠããŸãããŠã©ãŒãã³ã°ãçãã¬åŸã®å埩é£ãšããŠãæé©ã§ãã
3. ãã¿ãã³Cã§â代è¬åã¢ããâããµããŒã
ãã¿ãã³Cã¯ãè質代è¬ãã³ã©ãŒã²ã³çæãå ç«ã®ç¶æãªã©å€ãã®çççããã»ã¹ã«é¢äžããéèŠãªãã¿ãã³ã§ãã
ã¹ãã¬ã¹ãããããšæ¶èããããããããã¹ãã¬ã¹ãã«ãªçŸä»£äººã«ã¯ç¹ã«å¿ èŠã1æ¥2ã3åã®ã¿ããã§ããã¿ãã³Cã®å¿ èŠéãæè»œã«è£ããŸãã
4. çã¿ãããã®ã«âäœGIé£åâ
ã¿ããã®ç³è³ªã¯æç³ãšãããŠç³ãäžå¿ã§ãããæç©ã®äžã§ã¯æ¯èŒçGIå€ïŒè¡ç³äžæææ°ïŒãäœãã§ãã
è¡ç³å€ã®æ¥äžæãæããããšã§ãèèªèç©ãã«ã¢ã³ãã€ã³ã¹ãªã³ãã®åæ³ãç·©ããã«ã§ããå¯èœæ§ããããŸããè¡ç³ã³ã³ãããŒã«ãæèããé£ç掻ã«ãããŠããé©éã®ã¿ãããªãå®å¿ã§ãã
5. β-ã¯ãªããããµã³ãã³ã§âèèªççŒåâã«æåŸ
ã¿ããã®é®®ãããªãªã¬ã³ãžè²ã¯ãã«ãããã€ãã®äžçš®ãβ-ã¯ãªããããµã³ãã³ãã«ãããã®ã
ããã¯èèªçްèã®ççãæããå¯èœæ§ãããæ é€çŽ ã§ãäœå ã®ä»£è¬ãã©ã³ã¹ãæŽãããµããŒããããŠãããããšãç¥ãããŠããŸãã
ãé£ã¹ããæ³šæãã§ããã€ãšããã®â峿¹âã«ã§ããçç±
ãã¿ããã¯çããã倪ãããšæãããã¡ã§ããã1æ¥ã«2ã3åãŸã§ãç®å®ã«ããã°ãç³è³ªã®éå°æåã«ããªãã«ãããæ é€ãã©ã³ã¹ãæŽããäžå©ã«ãªããŸãã
ãŸããããã€ãšããŠèåãã³ãã¹ããã¯èåãé£ã¹ãããããã¿ãããéžã¶æ¹ãã¯ããã«äœã«ããªãŒã§é«æ é€ã
èªç¶ãªçã¿ãšæ°Žåã§**âå£å¯ããâãæºãã眮ãæããã«ãŒã**ãšããŠæŽ»çšã§ããŸãã
ãããªäººã«ããããïŒã¿ãããã€ãšãã
- ã¹ãã¬ã¹ã§éé£ãå¢ããã¡
- é£åŸã®ãã¶ãŒãããããããªã
- å€é£ãå å·¥é£åãå€ãããã¿ãã³ãäžè¶³ããã¡
- è žå ç°å¢ãæŽããã
- å¬ã§ãéåããŠãã or 掻åéãå€ã
ã¿ããã¯ãé£ã¹ãããªããã°ãæè»œã§æç¶ãããããã€ãšããè£å©é£ãã§ããç¹ã«ãâé£ã¹ãªããå¥åº·ç®¡çããããâäººã«æé©ã
ããããã®é£ã¹æ¹ïœãã€ãšããã«å¹ãããã³ã
âãç®ããšé£ã¹ããæèŠã§
çœãçãèç®ã«ã¯æ é€ããã£ã·ããã§ããã ãæ®ããé£ã¹ãããšã§ãé£ç©ç¹ç¶ãšããªãã§ããŒã«ããã£ããæåã§ããŸãã
âæãéé£ã¿ã€ã ã«
è¡ç³å€ãå®å®ããŠããæé垯ã«åãå ¥ããã®ãçæ³ãæé£ã®äžéšã15æååŸã®éé£ã«ããã®ãããããã§ãã
âå·ãããããªã
å·èµåº«ã§å·ããããããšãå èãå·ããŠä»£è¬ãèœã¡ãå¯èœæ§ããåžžæž©ã§ä¿åããŠãããããæž©ããäœã«ããããçã¿ã楜ãã¿ãŸãããã
ãããã質åïŒFAQïŒ
Q. ã¿ããã¯å€ã«é£ã¹ããšå€ªãïŒ
A. å€ã«å€§éã«é£ã¹ããšãç³è³ªã®æãããã«ãªããããã§ããå€ã«é£ã¹ããªã1åãŸã§ãå€é£ã®åŸã§ã¯ãªãéé£ã¿ã€ã ã«åãå ¥ããã®ãããããã§ãã
ãŸãšãïœã¿ããã¯âè³¢ãé£ã¹ãã°âãã€ãšããã®å³æ¹
ã¿ããã¯çã¿ã®ããæç©ã§ãããé£ç©ç¹ç¶ããã¿ãã³Cãã¯ãšã³é žãªã©ããã€ãšãããå¥åº·ç¶æã«å¬ããæåãè©°ãŸã£ãåªç§ãªé£æã§ãã
ã»ç³è³ªãæ°ã«ãªã人ã§ãé©éãªãOK
ã»èã£ããé£äºãšã®çžæ§ãâïŒãµãããªæïŒ
ã»ãèåã®ä»£ããã«ãªãèªç¶æŽŸã¹ã€ãŒã
ãé£ã¹ãªããã€ãšããããããããéžãã§é£ã¹ããã€ãšããããžã
å¬ã®å³èŠã»ã¿ãããåãå ¥ããŠãç¡çãªããçŸå³ãããå¥åº·çãªãã€ãšãããå§ããŠã¿ãŸãããïŒ
â»â»æ¬èšäºã¯ãæ°R25ã«æ²èŒãããå®çžŸãæã¡ããã¬ãŒããŒé€æã¹ã¯ãŒã«ã®è¬åž«ãšããŠã掻åããäºäžè£åžãç£ä¿®ããŠããŸãã
å¥åº·ã»æ é€ã»ãã¬ãŒãã³ã°ã«é¢ããäžè¬çãªæ
å ±æäŸãç®çãšããŠãããå»çäžã®èšºæãæ²»çãç®çãšãããã®ã§ã¯ãããŸããã
äœèª¿ãçç¶ã«äžå®ãããæ¹ã¯ãå¿
ãå»åž«ãå°éã®å»çæ©é¢ã«ãçžè«ãã ããã
åèæç®ã»åŒçšå
- æéšç§åŠçãæ¥æ¬é£åæšæºæå衚2020幎çïŒå «èšïŒã
- åœç«å¥åº·ã»æ é€ç ç©¶æãé£åæåããŒã¿ããŒã¹ã
- èŸ²ææ°Žç£ç ææš¹ç ç©¶æãææ©é¡ã®æ©èœæ§æåã«é¢ããç ç©¶ã
- Nishino H, et al. (2002). “Inhibitory effects of β-cryptoxanthin on chemically induced tumorigenesis.” Cancer Letters.
- OâConnor, L. E., et al. (2015). “Low-Glycemic Index Diets and Weight Loss.” American Journal of Clinical Nutrition.
ã³ã¡ã³ã